• Issue

    Cancer Reports: Volume 5, Issue 2

    February 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 14 February 2022

ORIGINAL ARTICLE

Open Access

Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study

Jessa Gilda Pandy,  Omar Maaño,  Joanmarie C. Balolong-Garcia,  Jay T. Y. Datukan, 
  • First Published: 22 May 2021

CASE REPORT

Open Access

Forty-eight-year-old female MUTYH carrier presenting with five concurrent primary cancers

Aaron Arroyave,  Laurentia Nodit,  Devin Clegg,  Andrew Russ, 
  • First Published: 26 June 2021

ORIGINAL ARTICLES

Open Access

Tongue conservation treatment for oral tongue squamous cell carcinoma with induction chemotherapy, surgery, and risk-adapted adjuvant therapy: A phase II trial

Tsung-Lun Lee,  Pei-Yin Wei,  Muh-Hwa Yang,  Peter Mu-Hsin Chang,  Ling-Wei Wang,  Shyh-Kuan Tai, 
  • First Published: 29 May 2021
Open Access

A retrospective analysis of discharge summaries from a tertiary care hospital medical oncology unit: To assess compliance with documentation of recommended discharge summary components

Jingwei Ge,  Alison Davis,  Ankit Jain, 
  • First Published: 21 June 2021

CASE REPORT

Open Access

Description of longitudinal tumor evolution in a case of multiply relapsed clear cell sarcoma of the kidney

Tomoki Yaguchi,  Shunsuke Kimura,  Masahiro Sekiguchi,  Yasuo Kubota,  Masafumi Seki,  Kenichi Yoshida,  Yuichi Shiraishi,  Keisuke Kataoka,  Yoichi Fujii,  Kentaro Watanabe,  Mitsuteru Hiwatari,  Satoru Miyano,  Seishi Ogawa,  Junko Takita, 
  • First Published: 29 December 2021

ORIGINAL ARTICLE

Open Access

Multi-ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy

Alyssa A. Leystra,  Brock J. Gilsdorf,  Amanda M. Wisinger,  Elise R. Warda,  Shanna Wiegand,  Christopher D. Zahm,  Kristina A. Matkowskyj,  Dustin A. Deming,  Naghma Khan,  Quincy Rosemarie,  Chelsie K. Sievers,  Alexander R. Schwartz,  Dawn M. Albrecht,  Linda Clipson,  Hasan Mukhtar,  Michael A. Newton,  Richard B. Halberg, 
  • First Published: 10 July 2021

CASE REPORT

Open Access

Intracranial complete response for non-small-cell lung cancer patient with negative PD-L1 expression of the lung using nivolumab

Rui Kitadai,  Yoshitaka Zenke,  Tsunekazu Hishima,  Yukio Hosomi, 
  • First Published: 27 May 2021

ORIGINAL ARTICLES

Open Access

Cross-sectional study of psychosocial well-being among lesbian, gay, bisexual, and heterosexual gynecologic cancer survivors

Alexandra Schefter,  Lauren Thomaier,  Patricia Jewett,  Katherine Brown,  Ashley E. Stenzel,  Anne Blaes,  Deanna Teoh,  Rachel I. Vogel, 
  • First Published: 31 May 2021
Open Access

The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study

Jon Arne Søreide,  Jan Terje Kvaløy,  Dordi Lea,  Oddvar M. Sandvik,  Mohammed Al-Saiddi,  Torjan M. Haslerud,  Herish Garresori,  Lars N. Karlsen,  Einar Gudlaugsson,  Kjetil Søreide, 
  • First Published: 08 June 2021
Open Access

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

Atsushi Hiraoka,  Takashi Kumada,  Toshifumi Tada,  Masashi Hirooka,  Kazuya Kariyama,  Joji Tani,  Masanori Atsukawa,  Koichi Takaguchi,  Ei Itobayashi,  Shinya Fukunishi,  Kunihiko Tsuji,  Toru Ishikawa,  Kazuto Tajiri,  Hironori Ochi,  Satoshi Yasuda,  Hidenori Toyoda,  Chikara Ogawa,  Takashi Nishimura,  Takeshi Hatanaka,  Hideko Ohama,  Kazuhiro Nouso,  Asahiro Morishita,  Akemi Tsutsui,  Takuya Nagano,  Norio Itokawa,  Tomomi Okubo,  Taeang Arai,  Michitaka Imai,  Yohei Koizumi,  Shinichiro Nakamura,  Kouji Joko,  Hiroko Iijima,  Yoichi Hiasa,  Masatoshi Kudo,  Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (Hepatocellular Carcinoma Experts from 48 Clinics in Japan) , 
  • First Published: 11 June 2021
Open Access

Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution

Siddharth Menon,  Amy Davies,  Sophia Frentzas,  Cheryl-Ann Hawkins,  Eva Segelov,  Daphne Day,  Ben Markman, 
  • First Published: 10 July 2021

CASE REPORT

Open Access

Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review

Khalid Alshehri,  Yousuf Alqurashi,  Mazin Merdad,  Shaza Samargandy,  Razan Daghistani,  Hani Marzouki, 
  • First Published: 08 June 2021

ORIGINAL ARTICLES

Open Access

Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT

Joël Guigay,  Emmanuel Chamorey,  Gautier Lefebvre,  Maciej Rotarski,  Jean-Philippe Wagner,  Emmanuel Blot,  Marc Alfonsi,  Audrey Seronde,  Jeltje Schulten,  Frédéric Peyrade,  Christophe Le Tourneau, 
  • First Published: 22 June 2021
Open Access

The cost, survival, and quality-of-life implications of guideline-discordant imaging for prostate cancer

Aaron N. Winn,  Matthew Kelly,  Shannon Ciprut,  Dawn Walter,  Heather T. Gold,  Steven B. Zeliadt,  Scott E. Sherman,  Danil V. Makarov, 
  • First Published: 17 June 2021

CASE SERIES

Open Access

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

Evert S. M. van Aken,  Aart Beeker,  Ilse Houtenbos,  Floris J. Pos,  Sabine C. Linn,  Paula H. M. Elkhuizen,  Monique C. de Jong, 
  • First Published: 18 June 2021

CLINICAL RESEARCH ARTICLE

Open Access

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound

Naoki Kamachi,  Masahito Nakano,  Shusuke Okamura,  Takashi Niizeki,  Hideki Iwamoto,  Shigeo Shimose,  Tomotake Shirono,  Yu Noda,  Ryoko Kuromatsu,  Hironori Koga,  Takuji Torimura, 
  • First Published: 09 June 2021

CASE REPORTS

Open Access

Langerhans cell histiocytosis: Presentation in a preterm neonate

Ana Fadhel Alvarez,  Shaily P. Patel,  Maya I. Brasher,  Jaclyn E. Ruggiero,  Chiamaka Aneji, 
  • First Published: 22 June 2021
Open Access

Classical Hodgkin's lymphoma with cutaneous involvement in an adolescent male: A case study

Sumon Ghosh,  Sajib Ghosh,  Rownak Jahan Amin,  Fahmida Chowdhury,  Namala Satya Prasad,  Pandurangan Prabu,  Sukanta Chowdhury, 
  • First Published: 05 June 2021

REVIEW

Open Access

Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis

Judah Glogauer,  Jonathan Blay, 
  • First Published: 26 July 2021

ORIGINAL ARTICLE

Open Access

Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients

Yuka Kawaji-Kanayama,  Tsutomu Kobayashi,  Ayako Muramatsu,  Hitoji Uchiyama,  Nana Sasaki,  Nobuhiko Uoshima,  Mitsushige Nakao,  Ryoichi Takahashi,  Kazuho Shimura,  Hiroto Kaneko,  Miki Kiyota,  Katsuya Wada,  Yoshiaki Chinen,  Koichi Hirakawa,  Shin-ichi Fuchida,  Chihiro Shimazaki,  Yayoi Matsumura-Kimoto,  Shinsuke Mizutani,  Taku Tsukamoto,  Yuji Shimura,  Shigeo Horiike,  Masafumi Taniwaki,  Junya Kuroda,  Kyoto Clinical Hematology Study Group (KOTOSG) Investigators , 
  • First Published: 14 June 2021